glyburide has been researched along with simendan in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 9 (56.25) | 29.6817 |
2010's | 5 (31.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katsube, Y; Sperelakis, N; Sunagawa, M; Yokoshiki, H | 1 |
Du Toit, EF; McCarthy, J; Muller, CA; Opie, LH | 1 |
Kersten, JR; Montgomery, MW; Pagel, PS; Warltier, DC | 1 |
Haikala, H; Kaheinen, P; Levijoki, J; Pollesello, P | 1 |
Höhn, J; Krassói, I; Kun, A; Papp, JG; Pataricza, J | 1 |
Balogh, A; Höhn, J; Papp, JG; Pataricza, J; Petri, A; Tóth, GK; Varró, A | 1 |
Abrass, CK; Hanson, SY; Johnson, AC; Lund, S; Zager, RA | 1 |
Baskurt, OK; Meiselman, HJ; Ozdem, SS; Usta, C; Yalcin, O | 1 |
Demirkilic, U; Nacitarhan, C; Seyrek, M; Yildirim, V; Yildiz, O | 1 |
Bigat, Z; Eksert, B; Gölbasi, I; Ozdem, SS; Usta, C | 1 |
Akar, F; Katircioglu, SF; Manavbasi, Y; Parlar, AI; Ulus, AT | 1 |
Hehir, MP; Morrison, JJ; Moynihan, AT | 1 |
Picker, O; Schober, P; Schwarte, LA; Schwartges, I; Thomas, K | 1 |
Babelova, A; Brandes, RP; Buerkl, J; Hofstetter, C; Kirschning, T; Mieth, A; Neofitidou, S; Revermann, M; Schermuly, RT; Schloss, M; Schröder, K | 1 |
Bauer, I; Beck, C; Picker, O; Vollmer, C; Weiß, S | 1 |
Babik, B; Balogh, AL; Fodor, GH; Ivankovitsne-Kiss, O; Petak, F; Sudy, R | 1 |
1 trial(s) available for glyburide and simendan
Article | Year |
---|---|
Levosimendan attenuates pulmonary vascular remodeling.
Topics: Airway Remodeling; Animals; Cardiotonic Agents; Disease Models, Animal; Germany; Glyburide; Hydrazones; Hypertension, Pulmonary; Hypoglycemic Agents; Myocardial Contraction; Nicorandil; Potassium Channels; Pulmonary Circulation; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan; Vasodilator Agents | 2011 |
15 other study(ies) available for glyburide and simendan
Article | Year |
---|---|
Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cells, Cultured; Charybdotoxin; Enzyme Inhibitors; Female; Glyburide; Hydrazones; Hypoglycemic Agents; Male; Membrane Potentials; Mesenteric Arteries; Patch-Clamp Techniques; Potassium Channels; Pyridazines; Rats; Simendan; Vasodilator Agents | 1997 |
Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Agonists; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Dobutamine; Glyburide; Guinea Pigs; Heart; Hydrazones; In Vitro Techniques; L-Lactate Dehydrogenase; Lactic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nucleotides, Cyclic; Phosphocreatine; Pyridazines; Simendan; Stereoisomerism | 1999 |
Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels.
Topics: Animals; ATP-Binding Cassette Transporters; Cardiotonic Agents; Dogs; Glyburide; Hemodynamics; Hydrazones; Hypoglycemic Agents; KATP Channels; Microspheres; Myocardial Infarction; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyridazines; Simendan; Ventricular Function, Left | 2000 |
Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels.
Topics: Animals; Coronary Circulation; Female; Glyburide; Guinea Pigs; Heart; Heart Rate; Hydrazones; Hypoglycemic Agents; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Pinacidil; Potassium Channels; Pyridazines; Simendan; Vasodilator Agents | 2001 |
Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Animals; Calcium; Coronary Vessels; Cromakalim; Glyburide; Hydrazones; In Vitro Techniques; Ion Channel Gating; Isometric Contraction; Muscle, Smooth, Vascular; Peptides; Potassium Channel Blockers; Potassium Channels; Pyridazines; Simendan; Swine; Tetraethylammonium; Vasodilator Agents | 2003 |
Levosimendan interacts with potassium channel blockers in human saphenous veins.
Topics: Drug Interactions; Glyburide; Humans; Hydrazones; In Vitro Techniques; Peptides; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Pyridazines; Saphenous Vein; Serotonin; Simendan; Vasodilation; Vasodilator Agents | 2004 |
Levosimendan protects against experimental endotoxemic acute renal failure.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Cardiotonic Agents; Chemokine CCL2; Endotoxemia; Glyburide; Hydrazones; Inflammation; Ischemia; Kidney; Lipopolysaccharides; Male; Mesangial Cells; Mice; Nitric Oxide; Potassium Channel Blockers; Potassium Channels; Pyridazines; Simendan; Tumor Necrosis Factor-alpha | 2006 |
The role of potassium channels in relaxant effect of levosimendan in rat small mesenteric arteries.
Topics: Animals; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Hydrazones; In Vitro Techniques; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Potassium Channels, Inwardly Rectifying; Potassium Chloride; Pyridazines; Rats; Rats, Wistar; Simendan; Vasodilation; Vasodilator Agents | 2006 |
Potassium channel-related relaxation by levosimendan in the human internal mammary artery.
Topics: Aged; Anti-Arrhythmia Agents; Female; Glyburide; Humans; Hydrazones; In Vitro Techniques; Male; Mammary Arteries; Middle Aged; Potassium Channels; Pyridazines; Simendan; Vasodilation; Vasodilator Agents | 2006 |
The role of potassium channels in the vasodilatory effect of levosimendan in human internal thoracic arteries.
Topics: Aged; Cardiotonic Agents; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Humans; Hydrazones; Mammary Arteries; Middle Aged; Phenylephrine; Phosphodiesterase Inhibitors; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Pyridazines; Simendan; Tissue Culture Techniques; Vasodilation; Vasodilator Agents | 2006 |
The gender differences in the relaxation to levosimendan of human internal mammary artery.
Topics: 4-Aminopyridine; Anti-Arrhythmia Agents; Charybdotoxin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Glyburide; Humans; Hydrazones; Male; Mammary Arteries; Middle Aged; Potassium Channel Blockers; Pyridazines; Sex Characteristics; Simendan; Vasodilation | 2007 |
Relaxant effect of Levosimendan on human uterine contractility in vitro.
Topics: Case-Control Studies; Dose-Response Relationship, Drug; Female; Glyburide; Humans; Hydrazones; In Vitro Techniques; Muscle Relaxation; Myometrium; Oxytocin; Pyridazines; Reference Values; Sensitivity and Specificity; Simendan; Tissue Preservation; Uterine Contraction | 2010 |
The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia.
Topics: Acute Disease; Adenosine Triphosphate; Animals; Dogs; Glyburide; Hemodynamics; Hydrazones; Hypoglycemic Agents; Hypoxia; Metabolism; Microcirculation; Models, Animal; Pyridazines; Simendan; Vasodilator Agents | 2011 |
Hypothermia improves oral and gastric mucosal oxygenation during hypoxic challenges.
Topics: Animals; Cardiac Output; Cardiotonic Agents; Cross-Over Studies; Disease Models, Animal; Dogs; Female; Gastric Mucosa; Glyburide; Hydrazones; Hypoglycemic Agents; Hypothermia, Induced; Hypoxia; Laser-Doppler Flowmetry; Microcirculation; Mouth Mucosa; Oxygen; Pyridazines; Simendan | 2014 |
Levosimendan prevents bronchoconstriction and adverse respiratory tissue mechanical changes in rabbits.
Topics: Airway Resistance; Animals; Bronchial Hyperreactivity; Bronchoconstriction; Cardiac Output; Disease Models, Animal; Glyburide; Hydrazones; KATP Channels; Lung; Male; Methacholine Chloride; Pyridazines; Rabbits; Simendan | 2017 |